Anti-CD7 antibody [EPR22065]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(2 Publications)
Rabbit Recombinant Monoclonal CD7 antibody. Suitable for IP, Flow Cyt, WB, ICC/IF and reacts with Human samples. Cited in 2 publications.
View Alternative Names
CD7, T-cell antigen CD7, GP40, T-cell leukemia antigen, T-cell surface antigen Leu-9, TP41
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-CD7 antibody [EPR22065] (AB224194)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized MOLT-4 (human lymphoblastic leukemia cell line) cells labeling CD7 with ab224194 at 1/100 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing Membranous staining in MOLT-4 cells. The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) at 1/200 dilution (red).
PDS only control : Used PBS instead of primary antibody, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.
Negative control : Raji (PMID : 16332967).
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-CD7 antibody [EPR22065] (AB224194)
Human PBMCs (peripheral blood mononuclear cells) were stained with Alexa Fluor® 647-conjugated anti-human CD3 and rabbit IgG - ab172730 (Left) or CD7 - ab224194 at 1/500 (Right). Goat anti-Rabbit IgG Fc (Dylight® 488, ab98462), at 1/2000 dilution was used as the secondary antibody. Data shown was gated on viable cells. The expression pattern of CD7 is consistent with literature. (PMID : 3260936)
- IP
Supplier Data
Immunoprecipitation - Anti-CD7 antibody [EPR22065] (AB224194)
CD7 was immunoprecipitated from 0.35 mg of human tonsil lysate with ab224194 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab224194 at 1/500 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1000 dilution.
Lane 1 : Human tonsil lysate 10 μg (Input).
Lane 2 : ab224194 IP in human tonsil lysate lysate (+).
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab224194 in human tonsil lysate (-).
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 30 seconds.
All lanes:
Immunoprecipitation - Anti-CD7 antibody [EPR22065] (ab224194)
Predicted band size: 25 kDa
Observed band size: 37 kDa
false
- WB
Supplier Data
Western blot - Anti-CD7 antibody [EPR22065] (AB224194)
Blocking and dilution buffer : 5% NFDM/TBST.
This blot was developed using a higher sensitivity ECL substrate.
The molecular mass observed is consistent with what has been described in the literature (PMID : 24157461, PMID : 2479685); the actual size different from the predicted is due to glycosylation (PMID : 2479685).
Negative control : Raji (PMID : 1633296, PMID : 11389079).
All lanes:
Western blot - Anti-CD7 antibody [EPR22065] (ab224194) at 1/1000 dilution
Lane 1:
MOLT-4 (human lymphoblastic leukemia cell line) whole cell lysate at 20 µg
Lane 2:
HepG2 (human liver hepatocellular carcinoma cell line) whole cell lysate at 20 µg
Lane 3:
Raji (human Burkitt's lymphoma cell line) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution
Predicted band size: 25 kDa
Observed band size: 37 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-CD7 antibody [EPR22065] (AB224194)
Blocking and dilution buffer : 5% NFDM/TBST.
Exposure times :
Lane 1 : 3 minutes
Lane 2 : 48 seconds
This blot was developed using a higher sensitivity ECL substrate.
The molecular mass observed is consistent with what has been described in the literature (PMID : 24157461, PMID : 2479685); the actual size different from the predicted is due to glycosylation (PMID : 2479685).
All lanes:
Western blot - Anti-CD7 antibody [EPR22065] (ab224194) at 1/1000 dilution
Lane 1:
Human tonsil lysate at 20 µg
Lane 2:
Human thymus lysate at 20 µg
Secondary
All lanes:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution
Predicted band size: 25 kDa
Observed band size: 37 kDa
false
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CD7 plays a role in modulating interactions between immune cells without being part of a larger complex. It bridges interactions promoting immune responses by influencing T cell proliferation and cytokine production. CD7 control is important in regulating immune response intensity and provides an essential checkpoint in immune system modulation. Variations in CD7 function can significantly influence immune cell behavior impacting host defense mechanisms.
Pathways
CD7 participates in immune signaling pathways such as the T-cell receptor (TCR) signaling pathway. This pathway is essential for T cell activation and involves proteins like CD3 and ZAP-70 which work together with CD7 to transduce activation signals. Alterations in the CD7 pathway can affect the downstream signaling events leading to changes in immune cell activation and function.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
ACS omega 10:17416-17434 PubMed40352528
2025
Applications
Unspecified application
Species
Unspecified reactive species
iMeta 3:e221 PubMed39135698
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com